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Learning Objectives
1. The audience will understand 
concepts behind remotely guided 
echocardiographic imaging from 
remote locations such as the ISS. 
2. The audience will understand the 
approach of Benjamini, Krieger 
and Yekutieli (2001) to allow a 
moderate “false discovery rate” 
and modify the standard P-value 
threshold from 0.05 to a lower 
value for declaring “significance”
3. The audience will understand this 
study found no consistent effects 
of long-duration space flight on 
echocardiographic variables of the 
given group of subjects.
Introduction
• A number of echocardiographic research 
projects and experiments have been flown on 
almost every space vehicle since 1970, but 
validation of standard methods and the 
determination of ‘Space Normal’ cardiac 
function has not been reported to date 
• Advanced Diagnostics in Microgravity (ADUM) -
remote guided echocardiographic technique 
provides a novel and effective approach to on-
board assessment of cardiac physiology and 
structure using a just-in-time training algorithm 
and real-time remote guidance aboard the 
International Space Station (ISS)
Introduction – Cont.
• The validation of remotely guided 
echocardiographic techniques provides the 
procedures and protocols to perform scientific 
and clinical echocardiography on the ISS and the 
Moon 
• The objectives of this study were:
1. To confirm the ability of non-physician 
astronaut/cosmonaut crewmembers to perform 
clinically relevant remotely guided echocardiography 
using the Human Research Facility on board the ISS
2. To compare the preflight, postflight and in-flight 
echocardiographic parameters commonly used in 
clinical medicine

Cardiac Monitoring Occurrences
• Selection
• Annual 
physicals
• Parabolic 
flight
• Preflight
• In Flight
• Postflight
7• CD-ROM based “just-in-time” On Board 
Proficiency Enhancement (OPE) will 
reduce the amount of ground-based 
guidance needed to acquire advanced 
ultrasound images.
OPE
Make it Fun!!!!
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Is cardiac function a significant concern and 
should it be monitored?
• Need on-orbit echo data 
with cardiovascular 
interventions to better 
understand the 
physiology and space 
normal clinical findings
• In the past, astronauts 
have not been able to 
“get the shot” for 
retrospective analysis
• Pre/Post flight data are 
high fidelity because 
experience echo 
technicians are collecting 
the data
Space
Earth
Baseline 
ultrasound exam
~R+107 days 
(Russia)
Baseline ultrasound 
scan and simulation 
training
~L-240 days 
(Incr. 8 - August 2003)
POSTFLIGHTIN FLIGHTPREFLIGHT
Exam Scan 
(Cardiac, Thoracic, 
Abdominal, Bone ,Muscle)
Experiment Design
** “Restricted access” voice loop required
Notes: 
Restricted Audio/Video Communication for real-time remote guidance 
sessions.
OPE (all increments)
Operator only  7 days before 
scan
Session Analyses **
Within 7 days post scans set
On-board Proficiency 
Enhancer (OPE) and 
Preflight
~L-180 and 3 days
Methods
• Each crewmember operator (n=6) had 2h preflight 
training. Baseline data were collected 55 to 
167days preflight with HDI-5000 (ATL/Philips, 
Bothell, WA) ultrasound system 
• Similar equipment was used in each 60-minute in-
flight session (microgravity exposure - 114 days (34 
– 190)  
• Operators used an e-learning system (in this case, 
OPE) within 24h of these sessions. An expert in 
echocardiography provided assistance using 
ultrasound video downlink and 2-way voice 
• Testing was repeated 5 to 16 days after landing    
Data Analysis
• Separate ANOVA was used on each echocardiographic 
variable (n=36)
• Within each ANOVA, three tests were made:
A. effect of mission phase (preflight, in flight, postflight)
B. effect of echo technician (two independently analyzed 
the data)
C. interaction between mission phase and technician. 
• In the resulting 108 tests, some of the “significant” 
findings (P < 0.05) were expected to be false 
• A “false discovery rate” of 15% was assumed (Benjamini, 
Krieger and Yekutieli approach) , still retaining enough 
power to identify potentially important effects of mission 
phase, technician, or both  
• A revised P-value threshold was calculated to be 0.0116 
Each analyst measured the 
following parameters
• LA Systolic Diameter
• LV Diastolic and Systolic 
Diameter Base Length  and 
Posterior Wall Thickness
• LV Mass (Simpson and m-mode)
• LV diastolic length=a+d (cm)
• LV Outflow Tract Diameter 
and Time Velocity Integral
• RV Area Diastole and Systole
• RA Area Diastole and Systole
• % Change in RV and RA Area
• Mitral E and A-wave Velocity
• Atrioventricular Time Velocity 
Integral
• Fractional Shortening
• Ejection Fraction (by area and volume)
• Interventricular Septal Diastolic and 
Systolic Thickness
• Isovolumic Relaxation and 
Contraction Time
• Endocardial and Epicardial Area
• A Wave Duration
• Heart Rate 
• Diastolic and Systolic 4-Chamber 
Volume by 2D
• Cardiac Output
ADUM Cardiac Exam
The Method of Benjamini, 
Krieger and Yekutieli
• When running 108 tests (36 ANOVAS, 3 tests per each), some of 
the “significant” findings (corresponding to P < 0.05) might be 
spurious 
• To compensate for this, we used the approach of Benjamini, 
Krieger and Yekutieli to allow a moderate “false discovery rate” 
of 15%, but still retain enough power to identify potentially 
important mission phase, analyst, or interaction effects 
• Applying this procedure for our data resulted in a revised P-value 
threshold of 0.0116
• If this experiment and analysis procedure were to be repeated, 
one would expect on average that perhaps one or two of the 
rejections  of the NULL hypothesis were false 
The Method of Benjamini, 
Krieger and Yekutieli – Cont.
• “Significance” is only in a statistical sense and may not 
represent clinically meaningful differences
• 9 tests were “significant” (i.e., a rejection of the null 
hypothesis) using the method of Benjamini, Krieger and 
Yekutieli with an FDR of 0.15
– 6 rejections for significant technician effects (LV systolic 
diameter base length, LV posterior wall systolic thickness, A-wave duration, Inter-
ventricular septum diastolic and systolic thickness and LV mass) 
– 3 rejections of the null hypothesis were attributable 
to space flight (Atrio-ventricular velocity time integral, Mitral E wave, Heart 
rate) 

Results
• 9 rejections of the null hypothesis (mission phase or 
technician or both had no effect) were found that could 
be considered for possible follow up
• Of these
– 6 rejections were for significant technician effects 
– 3 were attributable to space flight
1. Atrioventricular velocity time integral
2. Mitral E wave
3. Heart Rate
• None were due to the interaction between technician 
and space flight
• Thus, we find no significant  effects of long-duration 
space flight on clinical echocardiographic variables for 
the given group of subjects
Conclusion
• Current ISS mission medical prevention strategies 
seem to prevent grossly obvious cardiac 
abnormalities
• Remotely guided echocardiography can be used 
for payload science and clinical studies where 
temporal communication delays are less than 6 
seconds (i.e., Moon and the Lagrange Point)
• If space-related changes in cardiovascular 
function measured by echocardiography exist, a 
larger cohort and more controlled conditions 
need to be implemented ( Integrate Cardiovascular Study 
– Levine and Bungo – currently manifested )
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